{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:10Z","timestamp":1792788610090,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014262","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bja.2025.11.057","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:42:47Z","timestamp":1770180167000},"page":"847-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimising protamine dosing for heparin reversal after cardiopulmonary bypass: a population pharmacokinetic\u2013pharmacodynamic study"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-3701","authenticated-orcid":false,"given":"Julien","family":"Lanoisel\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-7057","authenticated-orcid":false,"given":"Audrick","family":"Gibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-9005","authenticated-orcid":false,"given":"Isabelle","family":"Gouin-Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Pontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Morizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Goset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Molliex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Noyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Azarnoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andranik","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-0713","authenticated-orcid":false,"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-1195","authenticated-orcid":false,"given":"Paul J.","family":"Zufferey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-2941","authenticated-orcid":false,"given":"Edouard","family":"Ollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2025.11.057_bib1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bja.2025.01.015","article-title":"2024 EACTS\/EACTAIC\/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"134","author":"Wahba","year":"2025","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.057_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/aca.aca_117_23","article-title":"Protamine and heparin interactions: a narrative review","volume":"27","author":"Crivellari","year":"2024","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.bja.2025.11.057_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.057_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1213\/00000539-199810000-00008","article-title":"Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass","volume":"87","author":"Mochizuki","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.057_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/EJA.0b013e32833731bd","article-title":"The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph","volume":"27","author":"Khan","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.bja.2025.11.057_bib6","first-page":"290","article-title":"Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study","volume":"20","author":"Koster","year":"2014","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb"},{"key":"10.1016\/j.bja.2025.11.057_bib7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/icvts\/ivaa109","article-title":"A 0.6-protamine\/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products","volume":"31","author":"Goedhart","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.bja.2025.11.057_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0267659118763043","article-title":"The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass","volume":"33","author":"Kunz","year":"2018","journal-title":"Perfusion"},{"key":"10.1016\/j.bja.2025.11.057_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.jvca.2012.10.020","article-title":"Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery","volume":"27","author":"Galeone","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/j.jvca.2022.12.019","article-title":"Heparin rebound: an in-depth review","volume":"37","author":"Stone","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1177\/02676591231199218","article-title":"Does heparin rebound lead to postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass?","volume":"39","author":"Rijpkema","year":"2024","journal-title":"Perfusion"},{"key":"10.1016\/j.bja.2025.11.057_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40262-023-01334-3","article-title":"Factors influencing unfractionated heparin pharmacokinetics and pharmacodynamics during a cardiopulmonary bypass","volume":"63","author":"Gibert","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bja.2025.11.057_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.106553","article-title":"Robust K-PD model for activated clotting time prediction and UFH dose individualisation during cardiopulmonary bypass","volume":"214","author":"Chaux","year":"2022","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.bja.2025.11.057_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/bja\/aex044","article-title":"Pharmacokinetic\/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass","volume":"118","author":"Delavenne","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2025.11.057_bib15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jtcvs.2013.10.070","article-title":"Universal definition of perioperative bleeding in adult cardiac surgery","volume":"147","author":"Dyke","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2025.11.057_bib16","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1053\/j.jvca.2024.04.048","article-title":"On the reporting of protamine dosage in cardiac surgery","volume":"38","author":"Vandenheuvel","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1160\/TH16-02-0117","article-title":"Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial","volume":"116","author":"Meesters","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2025.11.057_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<112::AID-AJH7>3.0.CO;2-N","article-title":"Hemostatic effects of low-dose protamine following cardiopulmonary bypass","volume":"64","author":"Miyashita","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bja.2025.11.057_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/jth.12999","article-title":"Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management","volume":"13","author":"Hoenicka","year":"2015","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.bja.2025.11.057_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12630-022-02364-4","article-title":"Minimum protamine dose required to neutralize heparin in cardiac surgery: a single-centre, prospective, observational cohort study","volume":"70","author":"Taneja","year":"2023","journal-title":"Can J Anaesth J Can Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib21","article-title":"Comparison of blood concentration and weight-based heparin and protamine dosing strategies for cardiopulmonary bypass: a systematic review and meta-analysis","volume":"16","author":"Raner","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2025.11.057_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003658","article-title":"Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial","volume":"18","author":"Miles","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.bja.2025.11.057_bib23","first-page":"487","article-title":"An adjusted calculation model allows for reduced protamine doses without increasing blood loss in cardiac surgery","volume":"64","author":"Kjellberg","year":"2016","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2025.11.057_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/j.jvca.2018.07.044","article-title":"Calculation algorithm reduces protamine doses without increasing blood loss or the transfusion rate in cardiac surgery: results of a randomized controlled trial","volume":"33","author":"Kjellberg","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/0267659117695881","article-title":"Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass","volume":"32","author":"Miles","year":"2017","journal-title":"Perfusion"},{"key":"10.1016\/j.bja.2025.11.057_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/10892532251332464","article-title":"Comparison of three mathematical models of the pharmacokinetics of heparin to guide the use of protamine in a large simulated cohort of patients","volume":"29","author":"Vander Zwaag","year":"2025","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2025.11.057_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ALN.0000000000005256","article-title":"Protamine dosing for heparin reversal after cardiopulmonary bypass: a double-blinded prospective randomized control trial comparing two strategies","volume":"142","author":"Jain","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2025.11.057_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass","volume":"116","author":"Finley","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.057_bib29","first-page":"II420","article-title":"Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass","volume":"88","author":"Teoh","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2025.11.057_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0003-4975(02)04016-X","article-title":"Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass","volume":"74","author":"Butterworth","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bja.2025.11.057_bib31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00000539-200203000-00008","article-title":"The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers","volume":"94","author":"Butterworth","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.057_bib32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-0043-1770096","article-title":"Factors influencing anti-Xa assays: a multicenter prospective study in critically ill and noncritically ill patients receiving unfractionated heparin","volume":"123","author":"Lasne","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2025.11.057_bib33","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1515\/cclm-2020-0130","article-title":"Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data","volume":"58","author":"Hollestelle","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bja.2025.11.057_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtcvs.2003.12.023","article-title":"Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?","volume":"128","author":"Teoh","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2025.11.057_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1213\/ANE.0000000000002613","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: clinical practice guidelines-anticoagulation during cardiopulmonary bypass","volume":"126","author":"Shore-Lesserson","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2025.11.057_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-62703-339-8_19","article-title":"Anti-factor Xa (anti-Xa) assay","volume":"992","author":"Newall","year":"2013","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.bja.2025.11.057_bib37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtha.2024.01.001","article-title":"Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis","volume":"22","author":"Levy","year":"2024","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.bja.2025.11.057_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1051\/ject\/2023026","article-title":"Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding","volume":"55","author":"Lee","year":"2023","journal-title":"J Extra Corpor Technol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122500892X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000709122500892X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:02:32Z","timestamp":1773997352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000709122500892X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S000709122500892X"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.057","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising protamine dosing for heparin reversal after cardiopulmonary bypass: a population pharmacokinetic\u2013pharmacodynamic study","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2025.11.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}